“Unwrapping FDA’s UFA Package” –Catalyst To Moderate Panel During DIA/FDLI Meeting on Next Steps Under FDA Safety & Innovation Act

User fee expert and Catalyst Healthcare Consulting President Nancy Bradish Myers will serve as session moderator for a panel on implementation of recently enacted user fee legislation. The panel will cover key provisions under the reauthorized Prescription Drug User Fee Act (PDUFA), and the newly enacted user fee programs for both generic drugs (GDUFA) and biosimilars (BsUFA.)

The meeting is jointly sponsored by the Drug Information Association and the Food and Drug Law Institute. The conference program is available here

2018-05-28T01:44:05+00:00